GlassScriptPhysician profile
James A Germano
NPI 1811048838
$663,475.97
in general payments reported to CMS, 2019-2025
14 companies · $106K in 2025
The $106K reported for 2025 was more than what 97% of Orthopaedic Surgery providers received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $43K · 2020: $29K · 2021: $357K · 2022: $47K · 2023: $18K · 2024: $64K · 2025: $106K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $164K · Travel and Lodging: $14K · Food and Beverage: $8,546.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $164,479.92 |
| Travel and Lodging | $14,112.83 |
| Food and Beverage | $8,545.90 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Encore Medical, LP | $326,223.38 | 2021 | |
| Medical Device Business Services, INC. | $217,076.49 | 2019-2025 | Reclaim, Pinnacle, Pinnacle Gription |
| Stryker Corporation | $89,861.52 | 2019-2025 | Mako, Triathlon, Insignia |
| Depuy Synthes Products, INC. | $26,153.59 | 2020-2025 | Reclaim, Velys, Pinnacle Gription |
| Depuy Synthes Sales INC. | $1,778.02 | 2019-2025 | Attune, Actis, Velys |
| Next Science LLC | $679.91 | 2022 | |
| Zimmer Biomet Holdings, INC. | $503.04 | 2019-2023 | Saw Guide |
| Linvatec Corporation | $489.60 | 2022-2023 | Biobrace 23mm |
| Horizon Therapeutics Plc | $287.73 | 2019 | |
| Polaris Technology Solutions LLC | $156.71 | 2024 | |
| Heron Therapeutics, INC. | $119.48 | 2025 | Zynrelef |
| Smith+Nephew, INC. | $111.91 | 2022 | |
| Nevro Corp. | $34.59 | 2022 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$70,000.00 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Germano listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.